NCT07708454

Brief Summary

This study will investigate outcomes of a 3-month first-line treatment program for hand osteoarthritis, using data from the Swedish Osteoarthritis Registry.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2016

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2016

Completed
7.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2023

Completed
3.4 years until next milestone

First Submitted

Initial submission to the registry

July 13, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 16, 2026

Completed
Last Updated

July 16, 2026

Status Verified

July 1, 2026

Enrollment Period

7.1 years

First QC Date

July 13, 2026

Last Update Submit

July 13, 2026

Conditions

Keywords

OsteoarthritisFirst-line treatmentPhysical therapyexerciseeducationhand

Outcome Measures

Primary Outcomes (2)

  • NRS pain

    The NRS comprises an 11-point scale where 0 indicates no pain and 10 indicates the worst possible pain.

    From enrollment to 3 and 12 months follow-up, respectively

  • Health-related quality of life

    Assessed with the EuroQol - 5 dimension descriptive system (EQ-5D-3L)

    From enrollment to 3 and 12 months, respectively

Secondary Outcomes (4)

  • Pain frequency

    From enrollment to 3 and 12 months follow-up, respectively

  • Physical activity

    From enrollment to 3 and 12 months follow-up, respectively

  • Fear of movement

    from enrollment to 3 and 12 months follow-up, respectively

  • Willingness for surgery

    From enrollment to 3 and 12 months follow-up, respectively

Study Arms (1)

Hand osteoarthritis

Patients with a clinical diagnosis of hand osteoarthritis participating in a first-line treatment program

Other: 3 months of exercise and education

Interventions

Hand osteoarthritis

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with hand osteoarthritis registered in the Swedish Osteoarthritis register. The Swedish Osteoarthritis register is a national quality register evaluating the effect of first-line treatment on osteoarthritis-related outcomes.

You may qualify if:

  • \) a clinical diagnosis of hand OA, 2) Participated for three months in the program 3) reported any of the included outcomes at both baseline and at 3 months follow-up.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

OsteoarthritisMotor Activity

Interventions

ExerciseEducational Status

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaSocioeconomic FactorsPopulation Characteristics

Study Officials

  • Anna Cronström, PhD

    Lund University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 13, 2026

First Posted

July 16, 2026

Study Start

January 1, 2016

Primary Completion

January 31, 2023

Study Completion

January 31, 2023

Last Updated

July 16, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will share

De-identified IPD for primary and secondary outcomes will be made available upon reasonable request.

Access Criteria
The data used in this study contains sensitive information about the study participants and they did not provide consent for public data sharing. The current approval by the Regional Ethical Review Board, Sweden does not include data sharing. A minimal data set could be shared by request from a qualified academic investigator for the sole purpose of replicating the present study, provided the data transfer is in agreement with EU legislation on the general data protection regulation and approval by the Swedish Ethical Review Authority.